Is inverse association between lipoprotein(a) and diabetes mellitus another paradox in cardiometabolic medicine?

Donatos Tsamoulis, Constantine E. Kosmas, Loukianos S. Rallidis

Research output: Contribution to journalReview articlepeer-review

Abstract

Introduction: The impact of Type II Diabetes mellitus (T2DM) on cardiovascular disease (CVD) is well-established, while lipoprotein(a) [Lp(a)] has recently emerged as a recognized CVD risk factor. The rising prevalence of T2DM resulting from modern lifestyles and the development of specific Lp(a)-lowering agents brought the association between T2DM and Lp(a) in the forefront. Areas covered: Despite advancements in T2DM treatment, diabetic patients remain at very-high risk of CVD. Lp(a) may, to some extent, contribute to the persistent CVD risk seen in diabetic patients, and the coexistence of T2DM and elevated Lp(a) levels appears to synergistically amplify overall CVD risk. The relationship between T2DM and Lp(a) is paradoxical. On one hand, high Lp(a) plasma concentrations elevate the risk of diabetic microvascular and macrovascular complications. On the other hand, low Lp(a) plasma concentrations have been linked to an increased risk of developing T2DM. Expert opinion: Comprehending the association between T2DM and Lp(a) is critical due to the pivotal roles both entities play in overall CVD risk, as well as the unique aspects of their relationship. The mechanisms underlying the inverse association between T2DM and Lp(a) remain incompletely understood, necessitating further meticulous research.

Original languageEnglish
Pages (from-to)63-70
Number of pages8
JournalExpert Review of Endocrinology and Metabolism
Volume19
Issue number1
DOIs
StatePublished - 2024
Externally publishedYes

Keywords

  • Cardiovascular disease risk factors
  • T2DM-Lp(a) paradox
  • T2DM-Lp(a) synergistic effect
  • lipoprotein(a)
  • type 2 diabetes mellitus

Fingerprint

Dive into the research topics of 'Is inverse association between lipoprotein(a) and diabetes mellitus another paradox in cardiometabolic medicine?'. Together they form a unique fingerprint.

Cite this